4.6 Article

Hospital characteristics, clinical severity, and outcomes for surgical oncology patients

Journal

SURGERY
Volume 147, Issue 5, Pages 602-609

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.surg.2009.03.014

Keywords

-

Categories

Funding

  1. National Institute of Nursing Research [R01-NR04513, T32-NR07104]
  2. American Cancer Society [DSCN-03-202-01-SCN]
  3. Oncology Nursing Society

Ask authors/readers for more resources

Background. Patients and payers wish to identify hospitals with good surgical oncology outcomes. Our objective was to determine whether differences in outcomes explained by hospital structural characteristics are mitigated by differences in patient severity. Methods. Using hospital administrative and cancer registry records in Pennsylvania, we identified 24,618 adults hospitalized for cancer-related operations. Colorectal, prostate, endometrial, ovarian, head and neck, lung, esophageal, and pancreatic cancers were studied. Outcome measures were 30-day mortality and failure to rescue (FTR) (30-day mortality preceded by a complication). After severity of illness adjustment, we estimated logistic regression models to predict the likelihood of both outcomes. In addition to American Hospital Association survey data, we externally verified hospitals with National Cancer Institute (NCI) cancer center or Commission on Cancer (COG) cancer program status. Results. Patients in hospitals with NCI cancer centers were significantly younger and less acutely ill on admission (P < .001). Patients in. high volume hospitals were younger, had lower admission acuity, yet had more advanced cancer (P < .001). Unadjusted 30-day mortality rates were lower in NCI-designated hospitals (3.76% vs 2.17%; P = .01). Risk-adjusted KM rates were significantly lower in NCI-designated hospitals (4.86% vs 3.51%; P = .03). NCI center designation was a significant predictor of 30-day mortality when considering patient and hospital characteristics (OR, 0.68; 95% CI, 0.47-0.97; P = .04). We did not find significant outcomes effects based on. COG cancer program approval. Conclusion. Patient severity of illness varies significantly across hospitals, which may explain the outcome differences observed. Severity adjustment is crucial to understanding outcome differences. Outcomes were better than predicted for NCI-designated hospitals. (Surgery 2010;147:602-9.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Rescue Improvement Conference A Novel Tool for Addressing Failure to Rescue

Jennifer N. Ervin, C. Ann Vitous, Emily E. Wells, Sarah L. Krein, Christopher R. Friese, Amir A. Ghaferi

Summary: The effectiveness of the Rescue Improvement Conference in addressing postoperative complications was evaluated. The conference proved to be effective in promoting interdisciplinary collaboration, enabling the representation of diverse voices, and facilitating multilevel problem solving. It has the potential to support surgical departments in developing strategies to recognize and manage postoperative complications.

ANNALS OF SURGERY (2023)

Article Immunology

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study

Gowri Satyanarayana, Kyle T. Enriquez, Tianyi Sun, Elizabeth J. Klein, Maheen Abidi, Shailesh M. Advani, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Marilia Bernardes, Pamela C. Egan, Arielle Elkrief, Lawrence E. Feldman, Christopher R. Friese, Shipra Goel, Cyndi Gonzalez Gomez, Keith L. Grant, Elizabeth A. Griffiths, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Jayanshu Jain, Chinmay Jani, Anna Kaltsas, Anup Kasi, Hina Khan, Natalie Knox, Vadim S. Koshkin, Daniel H. Kwon, Chris Labaki, Gary H. Lyman, Rana R. McKay, Christopher McNair, Gayathri Nagaraj, Elizabeth S. Nakasone, Ryan Nguyen, Taylor K. Nonato, Adam J. Olszewski, Orestis A. Panagiotou, Matthew Puc, Pedram Razavi, Elizabeth Robilotti, Miriam Santos-Dutra, Andrew L. Schmidt, Dimpy P. Shah, Sumit A. Shah, Kendra Vieira, Lisa B. Weissmann, Trisha M. Wise-Draper, Ulysses Wu, Julie Tsu-Yu Wu, Toni K. Choueiri, Sanjay Mishra, Jeremy L. Warner, Benjamin French, Dimitrios Farmakiotis

Summary: This study aimed to investigate the frequency of coinfections and their association with outcomes among patients with cancer and COVID-19. The results showed that the risk of coinfections in this population was associated with factors such as age, sex, comorbidities, and disease status. Bacterial and fungal coinfections were found to be associated with higher mortality rates, while viral coinfections were less common.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

Jessica E. Hawley, Tianyi Sun, David D. Chism, Narjust Duma, Julie C. Fu, Na Tosha N. Gatson, Sanjay Mishra, Ryan H. Nguyen, Sonya A. Reid, Oscar K. Serrano, Sunny R. K. Singh, Neeta K. Venepalli, Ziad Bakouny, Babar Bashir, Mehmet A. Bilen, Paolo F. Caimi, Toni K. Choueiri, Scott J. Dawsey, Leslie A. Fecher, Daniel B. Flora, Christopher R. Friese, Michael J. Glover, Cyndi J. Gonzalez, Sharad Goyal, Thorvardur R. Halfdanarson, Dawn L. Hershman, Hina Khan, Chris Labaki, Mark A. Lewis, Rana R. McKay, Ian Messing, Nathan A. Pennell, Matthew Puc, Deepak Ravindranathan, Terence D. Rhodes, Andrea Rivera, John Roller, Gary K. Schwartz, Sumit A. Shah, Justin A. Shaya, Mitrianna Streckfuss, Michael A. Thompson, Elizabeth M. Wulff-Burchfield, Zhuoer Xie, Peter Paul Yu, Jeremy L. Warner, Dimpy P. Shah, Benjamin French, Clara Hwang

Summary: The study aimed to quantify spatiotemporal variation in COVID-19 outcomes among cancer patients in the US. Results showed no significant differences in outcomes across US census divisions, but substantial heterogeneity was found across cancer care delivery centers.

JAMA NETWORK OPEN (2022)

Article Oncology

COVID-19 vaccination and breakthrough infections in patients with cancer

A. L. Schmidt, C. Labaki, C-Y Hsu, Z. Bakouny, N. Balanchivadze, S. A. Berg, S. Blau, A. Daher, T. El Zarif, C. R. Friese, E. A. Griffiths, J. E. Hawley, B. Hayes-Lattin, V Karivedu, T. Latif, B. H. Mavromatis, R. R. McKay, G. Nagaraj, R. H. Nguyen, O. A. Panagiotou, A. J. Portuguese, M. Puc, M. Santos Dutra, B. A. Schroeder, A. Thakkar, E. M. Wulff-Burchfield, S. Mishra, D. Farmakiotis, Yu Shyr, J. L. Warner, T. K. Choueiri

Summary: This study analyzes the clinical features of cancer patients who develop symptomatic COVID-19 after vaccination. It finds that these patients often have comorbidities and can experience severe and even lethal infections. Hematologic malignancy patients are over-represented among the vaccinated cancer patients who develop symptomatic COVID-19. Therefore, while vaccination remains crucial in protecting vulnerable populations, including cancer patients, those who develop breakthrough infections despite full vaccination still face the risk of severe outcomes.

ANNALS OF ONCOLOGY (2022)

Article Oncology

Implementing patient navigation programs: Considerations and lessons learned from the Alliance to Advance Patient-Centered Cancer Care

Elizabeth S. Ver Hoeve, Melissa A. Simon, Sankirtana M. Danner, Antonio J. Washington, Susan D. Coples, Sanja Percac-Lima, Emma C. Whited, Electra D. Paskett, Michelle J. Naughton, Darrell M. Gray, Jennifer A. Wenzel, James R. Zabora, Ahmed Hassoon, Elliott E. Tolbert, Elizabeth Calhoun, Debra L. Barton, Christopher R. Friese, Marita G. Titler, Heidi A. Hamann

Summary: This article introduces the Alliance to Advance Patient-Centered Cancer Care, funded by the Merck Foundation, and shares insights from six cancer centers on patient navigation. The importance of understanding patient populations, utilizing existing infrastructure and institutional commitment, and mobilizing community support is highlighted.

CANCER (2022)

Editorial Material Medicine, General & Internal

Policy Strategies for Addressing Current Threats to the US Nursing Workforce

Deena Kelly Costa, Christopher R. Friese

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

Julie Fu, Sonya A. Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson, Narjust Duma, Sanjay Mishra, Ryan Nguyen, Jessica E. Hawley, Sunny R. K. Singh, David D. Chism, Neeta K. Venepalli, Jeremy L. Warner, Toni K. Choueiri, Andrew L. Schmidt, Leslie A. Fecher, Jennifer E. Girard, Mehmet A. Bilen, Deepak Ravindranathan, Sharad Goyal, Trisha M. Wise-Draper, Cathleen Park, Corrie A. Painter, Sheila M. McGlown, Gilberto de Lima Lopes Jr, Oscar K. Serrano, Dimpy P. Shah

Summary: This study aimed to investigate racial disparities in severity, clinical complications, and outcomes of COVID-19 between Black patients and non-Hispanic White patients with cancer. The study found that Black patients with cancer had worse COVID-19 outcomes, indicating a greater burden of COVID-19 in this population.

JAMA NETWORK OPEN (2022)

Article Oncology

IMPACT the Brain: A Team-Based Approach to Management of Metastatic Breast Cancer With CNS Metastases

Nicole M. Grogan Fleege, Donna Pierce-Gjeldum, Leigh K. Swartz, Kait Verbal, Sofia Merajver, Christopher R. Friese, Ayano Kiyota, Jason Heth, Denise Leung, Sean R. Smith, Nicolette Gabel, Michelle M. Kim, Aki Morikawa

Summary: The study aims to improve the survival and quality of life for patients with metastatic breast cancer through team-based care. The results show that a dedicated program coordinator and a personalized referral system can shorten patients' waiting time, improve the utilization of specialized medical resources, and facilitate patient participation in clinical trials.

JCO ONCOLOGY PRACTICE (2023)

Article Oncology

COVID-19 Outcomes by Cancer Status, Site, Treatment, and Vaccination

Maxwell Salvatore, Miriam M. Hu, Lauren J. Beesley, Alison M. Mondul, Celeste Leigh Pearce, Christopher R. Friese, Lars G. Fritsche, Bhramar Mukherjee

Summary: This study explores the association between cancer status, site, treatment, vaccination, and COVID-19 outcomes. Cancer diagnosis is associated with higher rates of severe COVID-19, hospitalization, and mortality, especially for recent cancer diagnoses. Certain cancer types and chemotherapy treatment increase the risk of worse COVID-19 outcomes, while vaccinations are associated with lower rates of severe COVID-19 outcomes.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Editorial Material Oncology

Technology Supports to Cancer Care Teams: Promises and Pitfalls

Cinzia Caparso, Christopher R. Friese

JCO ONCOLOGY PRACTICE (2023)

Article Oncology

Development, Feasibility, and Acceptability of an Oncologist Group Peer Support Program From ASCO's Clinician Well-Being Task Force

Fay J. Hlubocky, Daniel C. McFarland, Anthony L. Back, Christopher R. Friese, Laurel Lyckholm, Colleen M. Gallagher, Molly McGinnis, Rebecca Spence, Laura Lynch, Julia Tomkins, Tait Shanafelt, Piyush Srivastava

Summary: This study developed a virtual group peer support program for oncologists and found that it was feasible, acceptable, and beneficial for enhancing their well-being.

JCO ONCOLOGY PRACTICE (2023)

Article Oncology

Photo elicitation, an approach to better understanding the patient experience with OAAs: pilot study and future implications

Milisa Manojlovich, Amanda Blok, Nathan Wright, Emily Azhari, Karen B. Farris, Christopher R. Friese, Emily Mackler, Marita Titler, Mary Byrnes

Summary: This study explored the impact of side effects from oral anti-cancer agents (OAAs) on patients' lives and the strategies they used to manage these effects. Participants devised their own distinct strategies, including changing nutritional habits, using medication or non-medication approaches to alleviate side effects, and employing various coping methods.

SUPPORTIVE CARE IN CANCER (2023)

Article Oncology

Barriers, facilitators, and recommendations for sexual orientation and gender identity data collection in community oncology practices

Megan A. Mullins, Lisa Reber, Ariel Washington, Marina Stasenko, Aaron Rankin, Christopher R. Friese, Mary E. Cooley, Matthew F. Hudson, Lauren P. Wallner

Summary: Collecting sexual orientation and gender identity (SOGI) data in community oncology practices is crucial for addressing cancer inequities, but there are barriers such as low understanding, lack of infrastructure, and perceived low priority. Training, education, and support can help overcome these barriers and improve SOGI data collection.

CANCER MEDICINE (2023)

Article Oncology

Patients Recently Treated for B-lymphoid MalignanciesShow Increased Risk of Severe COVID-19

Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah, R. Alejandro Sica, Keith E. Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E. Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim Bilen, Cecilia A. Castellano, Jacob C. Cogan, K. C. Devendra, Christopher R. Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A. Johnson, Monika Joshi, Anup Kasi, Elizabeth J. Klein, Vadim S. Koshkin, Nicole M. Kuderer, Daniel H. Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H. Lyman, Rana R. McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K. Nonato, Adam J. Olszewski, Hyma Polimera, Andrew J. Portuguese, Matthew M. Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A. Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M. Wise-Draper, Leyre Zubiri, Jeremy L. Warner, Michael A. Thompson

Summary: Patients with B-lymphoid malignancies, especially those who have received recent anticancer therapy, are at a uniquely high risk of severe COVID-19.

BLOOD CANCER DISCOVERY (2022)

Article Geriatrics & Gerontology

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff-Burchfield, Rachel P. Rosovsky, Karen Vega-Luna, Michael A. Thompson, Orestis A. Panagiotou, Aakash Desai, Donna R. Rivera, Ali Raza Khaki, Lisa Tachiki, Ryan C. Lynch, Catherine Stratton, Rawad Elias, Gerald Batist, Anup Kasi, Dimpy P. Shah, Ziad Bakouny, Angelo Cabal, Jessica Clement, Jennifer Crowell, Becky Dixon, Christopher R. Friese, Stacy L. Fry, Punita Grover, Shuchi Gulati, Shilpa Gupta, Clara Hwang, Hina Khan, Soo Jung Kim, Elizabeth J. Klein, Chris Labaki, Rana R. McKay, Amanda Nizam, Nathan A. Pennell, Matthew Puc, Andrew L. Schmidt, Armin Shahrokni, Justin A. Shaya, Christopher T. Su, Sarah Wall, Nicole Williams, Trisha M. Wise-Draper, Sanjay Mishra, Petros Grivas, Benjamin French, Jeremy L. Warner, Tanya M. Wildes

Summary: This study aims to quantify the association of a novel geriatric risk index with COVID-19 severity and 30-day mortality among older adults with cancer. The results show a strong association between the geriatric risk index and COVID-19 severity and mortality, providing clinicians with a risk stratification method to identify high-risk older adults.

LANCET HEALTHY LONGEVITY (2022)

No Data Available